Zeke Capital Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,141
| Closed | -$240K | – | 487 |
|
|
2022
Q1 | $240K | Buy |
+1,141
| New | +$240K | 0.01% | 434 |
|
|
2020
Q1 | – | Sell |
-1,048
| Closed | -$311K | – | 266 |
|
|
2019
Q4 | $311K | Sell |
1,048
-13
| -1% | -$3.86K | 0.03% | 459 |
|
|
2019
Q3 | $247K | Sell |
1,061
-3,446
| -76% | -$802K | 0.02% | 483 |
|
|
2019
Q2 | $1.05M | Buy |
4,507
+23
| +0.5% | +$5.38K | 0.1% | 169 |
|
|
2019
Q1 | $1.06M | Sell |
4,484
-210
| -4% | -$49.6K | 0.1% | 169 |
|
|
2018
Q4 | $1.41M | Sell |
4,694
-3,562
| -43% | -$1.07M | 0.14% | 138 |
|
|
2018
Q3 | $2.92M | Hold |
8,256
| – | – | 0.24% | 71 |
|
|
2018
Q2 | $2.4M | Buy |
8,256
+4,461
| +118% | +$1.29M | 0.22% | 78 |
|
|
2018
Q1 | $1.04M | Sell |
3,795
-1,659
| -30% | -$454K | 0.1% | 190 |
|
|
2017
Q4 | $1.74M | Buy |
5,454
+1,689
| +45% | +$538K | 0.18% | 94 |
|
|
2017
Q3 | $1.18M | Buy |
3,765
+2,340
| +164% | +$733K | 0.16% | 102 |
|
|
2017
Q2 | $387K | Sell |
1,425
-59
| -4% | -$16K | 0.07% | 160 |
|
|
2017
Q1 | $406K | Buy |
1,484
+448
| +43% | +$123K | 0.08% | 142 |
|
|
2016
Q4 | $294K | Buy |
+1,036
| New | +$294K | 0.08% | 136 |
|